Nalaganje...

Hepatic inflammation and progressive liver fibrosis in chronic liver disease

Chronic liver inflammation drives hepatic fibrosis, and current immunosuppressive, anti-inflammatory, and anti-viral therapies can weaken this driver. Hepatic fibrosis is reversed, stabilized, or prevented in 57%-79% of patients by conventional treatment regimens, mainly by their anti-inflammatory a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Glavni avtor: Czaja, Albert J
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Co., Limited 2014
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3949261/
https://ncbi.nlm.nih.gov/pubmed/24627588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i10.2515
Oznake: Označite
Brez oznak, prvi označite!